|
Current and emerging therapies of HER2-positive metastatic breast cancer.
|
Hernández-Blanquisett Abraham, Touya Diego, Strasser-Weippl Kathrin, Ruiz Rossana, St Louis Jessica, Goss Paul
|
Breast (Edinburgh, Scotland). 2016 Oct; 29(Oct):170-7. doi: 10.1016/j.breast.2016.07.026. pii: S0960-9776(16)30136-9.
|
|
Escalating and de-escalating treatment in HER2-positive early breast cancer.
|
Joensuu Heikki
|
Cancer treatment reviews. 2017 Jan; 52(Jan):1-11. doi: 10.1016/j.ctrv.2016.11.002. pii: S0305-7372(16)30118-9.
|
|
Less is more? De-intensification of therapy for early-stage HER2-positive breast cancer.
|
Mathew Aju, Brufsky Adam
|
The Lancet. Oncology. 2017 04; 18(04):428-429. doi: 10.1016/S1470-2045(17)30150-X. pii: S1470-2045(17)30150-X.
|
|
Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?
|
Santa-Maria Cesar Augusto, Nye Lauren, Mutonga Martin B, Jain Sarika, Gradishar William J
|
Oncology (Williston Park, N.Y.). 2016 Feb; 30(Feb):148-55.
|
|
Optimal duration of trastuzumab for early HER2-positive breast cancer.
|
Specht Jennifer M, Davidson Nancy E
|
Lancet (London, England). 2017 03; 389(03):1167-1168. doi: 10.1016/S0140-6736(17)30322-7. pii: S0140-6736(17)30322-7.
|
|
Optimizing Treatment of HER2-Positive Breast Cancer.
|
Gradishar William J
|
Journal of the National Comprehensive Cancer Network : JNCCN. 2015 May; 13(May):649-51.
|
|
PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.
|
Huang Yi-Teng, Li Fei-Fei, Ke Chen, Li Zhou, Li Zong-Tai, Zou Xiao-Fang, Zheng Xiao-Xuan, Chen Yu-Ping, Zhang Hao
|
Journal of translational medicine. 2013 Oct; 11(Oct):245. doi: 10.1186/1479-5876-11-245. pii: .
|
|
Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.
|
Singh Jasmeet C, Mamtani Anita, Barrio Andrea, Morrow Monica, Sugarman Steven, Jones Lee W, Yu Anthony F, Argolo Daniel, Smyth Lilian M, Modi Shanu, Schweber Sarah, Boafo Camilla, Patil Sujata, Norton Larry, Baselga Jose, Hudis Clifford A, Dang Chau
|
The oncologist. 2017 02; 22(02):139-143. doi: 10.1634/theoncologist.2016-0268. pii: .
|